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Abstract 
Angiogenesis has been known as a hallmark of solid tumor cancers for decades, yet ultrasound has been 
limited in its ability to detect the microvascular changes associated with malignancy. Here, we 
demonstrate the potential of ‘ultrasound localization microscopy’ applied volumetrically in combination 
with quantitative analysis of microvascular morphology, as an approach to overcome this limitation. This 
pilot study demonstrates our ability to image complex microvascular patterns associated with tumor 
angiogenesis in-vivo at a resolution of tens of microns - substantially better than the diffraction limit of 
traditional clinical ultrasound, yet using an 8 MHz clinical ultrasound probe. Furthermore, it is observed 
that data from healthy and tumor-bearing tissue exhibit significant differences in microvascular pattern 
and density. Results suggests that with continued development of these novel technologies, ultrasound 
has the potential to detect biomarkers of cancer based on the microvascular ‘fingerprint’ of malignant 
angiogenesis rather than through imaging of blood flow dynamics or the tumor mass itself. 
Key words: Angiogenesis; super-resolution; ultrasound localization microscopy; microbubble contrast agent; 
acoustic angiography; biomarker. 
Introduction 
Early detection of disease is universally 
important for diagnostics and successful therapy. In 
solid tumors, the presence of angiogenesis has been 
recognized as an early hallmark of cancer for several 
decades [1,2]. Vessel structural abnormalities are 
known to reveal disease in very early stage, even after 
the introduction of tens of cells to the tissue [3,4]. 
These abnormalities can be resolved, or normalized, 
after positive response to treatment [5,6]. Despite this 
knowledge, we have been unable to utilize imaging 
tools to directly assess changes in microvascular 
morphology associated with angiogenesis as a 
biomarker clinically because relevant imaging 
modalities do not have the sensitivity and/or 
resolution to assess the microvascular structure 
associated with small tumors. 
Traditional grayscale ultrasound imaging is not 
very sensitive to blood flow in small vessels.  For this 
reason, ultrasound contrast agents (UCA) have been 
developed. These contrast agents can be administered 
intravenously to improve blood contrast in an 
imaging exam, and are FDA approved for use in 
cardiac and liver imaging in the United States, and are 
used even more extensively for other clinical 
applications in Europe and Asia. UCA are gas-filled 
encapsulated microbubbles, typically with mean 
diameter less than 5 µm, which oscillate and scatter 
energy in an ultrasound field, and thus can be 
detected with high sensitivity by an imaging system. 
Various techniques have been investigated to improve 
the quality of contrast enhanced ultrasound imaging 









responses of microbubbles to ultrasound waves. The 
resolution of classic ultrasound imaging is limited by 
the wavelength of the transmitted pulse, the aperture 
of the transducer, the imaging depth and the 
beamforming algorithm used [14]. Microbubbles 
appear as a point spread function (PSF) of the 
ultrasound system in an image, thus substantially 
degrading imaging resolution despite the micron-size 
of the bubbles themselves. 
Within these vascular imaging techniques, 
super-harmonic contrast ultrasound imaging has been 
utilized to image microvasculature in-vivo 
non-invasively. This approach, also called acoustic 
angiography because of image similarity to x-ray 
angiography, enables visualization of microvascular 
morphology in-vivo with resolution on the order of 
150 microns at 1.5 cm [15]. Data from acoustic 
angiography studies have shown that microvascular 
morphology abnormalities associated with 
tumor-induced angiogenesis can be detected for 
tumors as small as 2-3 millimeters, and can be used to 
differentiate between tumor bearing tissue and 
healthy tissue [13,16–19]. These findings support the 
concept that detection and analysis of microvascular 
changes due to tumor angiogenesis could be utilized 
as a cancer biomarker. Furthermore, angiogenesis 
biomarker imaging could be accomplished with 
low-cost, safe, and portable ultrasound technology. 
Super-harmonic imaging based acoustic angiography 
takes advantage of the unique superharmonic signal 
from microbubbles and a high-resolution ultrasound 
receiver to enable visualization of microvessel 
patterns and differentiation from surrounding tissue 
[15]. Nevertheless, this technique still suffers from the 
resolution limit of ultrasound imaging and the 
compromise between resolution and imaging depth. 
These limitations prevent current ultrasound imaging 
approaches from resolving details of microvascular 
networks where vessels are below approximately 100 
microns, even with advanced contrast ultrasound 
techniques such as super-harmonic imaging. 
Recently, researchers in the medical ultrasound 
domain have made effort to mimic the revolutionary 
technology of optical localization microscopy [20,21]. 
Optical localization microscopy exploits the stochastic 
blinking of specific fluorescent sources and localizes 
the center of each separable source. By accumulating 
these center positions over thousands of acquisitions, 
the resulting image achieves a ten-fold resolution 
improvement and enables imaging of cell membranes 
and small organelles [22]. In the medical ultrasound 
domain, different techniques have been investigated 
to achieve an ultrasound super resolution image, 
using contrast agent microbubbles as an acoustic 
equivalent of these fluorescent sources. Some groups 
used highly diluted contrast agents to meet the key 
requisite of separable microbubbles detection [23,24]. 
Although these groups obtained super-resolved 
images using conventional ultrasound scanners, the 
long acquisition time necessary to perform diluted 
microbubble super resolution imaging is likely to 
impinge upon its practicality. Tanter’s group used 
ultrafast acquisition and spatiotemporal filter to 
separate microbubbles from a high concentration, by 
exploiting the decorrelation of microbubbles from a 
stack of images [25,26]. This technique is a direct 
analog to FPALM in optics and the acquisition time is 
more reasonable for clinical translation. By localizing 
the centers of separable scattering microbubbles, this 
ultrasound localization microscopy (ULM) technique 
enables imaging of microvessels at resolutions as 
small as ten micrometers, over an order of magnitude 
smaller than the ultrasound diffraction limit. 
Super-resolved vasculature maps of rat brain slices 
using ULM technique have been shown in previous 
studies [26], although an application to 
tumor-associated angiogenesis has not yet been 
demonstrated. 
We hypothesize that the paradigm-shift of 
ultrasound localization microscopy enabled by 
high-frame rate imaging systems provides a new 
opportunity to image microvessels involved in tumor 
angiogenesis. In this pilot, we demonstrate that 
ultrasound localization microscopy can achieve 
similar vessel morphology data as acoustic 
angiography, yet with improved spatial resolution.  
Since microvascular morphology analysis requires 
assessment of microvascular structure within a tissue 
volume, we customize a programmable research 
ultrasound system to perform the ULM technique in 3 
dimensions through synchronization with a 
mechanical scanning system.  We then obtain 3D 
images of microvascular architecture from healthy 
rats and tumor-bearing rats noninvasively. Data are 
analyzed quantitatively and compared to 
super-harmonic imaging based acoustic angiography. 
Data illustrate a substantial improvement in imaging 
resolution over traditional acoustic angiography and 
analysis of vascular morphology suggests that 3D 
ULM based acoustic angiography should have the 
ability to differentiate healthy from diseased tissue, 
based on the high-resolution imaging of 
microvascular morphology alone. 
Methods 
In order to validate improvements in resolution 
via the ULM technique, in vitro studies were first 
conducted using simulated vessels from thin-walled 
polycarbonate microtubes (Paradigm Optics Inc., WA, 
USA) with inner diameters of 150 µm, 75 µm and 50 





µm. The imaging system and parameters for the 
in-vitro study were the same as those used for in vivo 
study. 
In vivo studies were conducted on female 
Fischer 344 rats (approximately 200 g, Charles River 
Laboratories, Durham, NC). Animal studies were 
approved by the University of North Carolina 
Institutional Animal Care and Use Committee. 
Tumor-bearing rats were implanted with 
subcutaneous fibrosarcoma (FSA; originally provided 
by the laboratory of Dr. Mark Dewhirst) tumors in the 
right flank region and were imaged after the tumor 
had grown larger than 0.5 cm in each axis. Healthy 
rats of the same species, age and sex were used as 
control rats and were imaged at the same anatomic 
location as tumor-bearing rats. Imaging was 
performed after anesthetizing the rats with vaporized 
isoflurane and placing them on a warming stage to 
maintain body temperature. The right flank was 
shaved and depilated to remove the hair, and 
ultrasound gel was applied to couple the transducer 
to the skin. Microbubbles were infused through a 
24-gauge tail-vein catheter at the rate of 1×108 
bubbles/min, with the aid of an infusion pump 
(Harvard Apparatus, Holliston, Mass). 
Lipid-encapsulated microbubble contrast agents 
containing decafluorobutane (SynQuest Labs, 
Alachua, FL, USA) were prepared as described 
previously [27], resulting in a polydisperse size 
distribution of contrast agents with a mean diameter 
of 0.9 μm and a concentration of 1×1010 bubbles per 
milliliter. Specifically, the bubbles were prepared with 
a 9:1 molar mixture of 1,2-distearoyl-sn-glycero- 
3-phosphocholine (DSPC, Avanti Polar Lipids, 
Alabaster, AL, USA) and 1,2-distearoyl-sn-glycero- 
3-phosphoethanolamine-N-[methoxy(polyethylene 
glycol)-2000] (mPEG-DSPE, Creative PEGWorks, 
Winston Salem, NC, USA) in phosphate buffered 
saline containing 15% (v/v) propylene glycol and 5% 
(v/v) glycerol. The lipid solution was then agitated 
with a Vialmix mixer (Bristol-Myers Squibb Medical 
Imaging, North Billerica, MA, USA) to create 
microbubbles. 
Imaging was performed using a Verasonics 
Vantage system (Verasonics Inc., Redmond, WA, 
USA) with a L11-5 linear probe, using plane-wave 
imaging at a pulse repetition frequency of 500 Hz. The 
transmitted pulses were 1 cycle sinusoids at 4.5 MHz 
with a rarefactional pressure of 220 kPa (mechanical 
index = 0.1). This low mechanical index was chosen to 
minimize bubble destruction under high frame rate 
insonification. The transducer was mounted to a 
motorized precision motion stage synchronized with 
the imaging system for 3D scanning. 8,000 images 
were acquired for each scan slice and slice step size 
was 200 µm.  Although ideally a smaller step size 
would have enabled superior volumetric 
reconstruction, elevational sampling was sacrificed in 
order to keep the imaging time less than 35 minutes, 
in order to limit the anesthesia and infusion time. IQ 
data were saved for post-processing. All rats were 
also imaged with traditional super-harmonic imaging 
based acoustic angiography technique [15,16] for 
comparison. Traditional acoustic angiography images 
were acquired by a Vevo 770 ultrasound scanner 
(VisualSonics, Toronto, ON, CA) with a modified 
transmit 4 MHz/receive 25 MHz dual-frequency 
transducer operating at a MI of 0.6, as previously 
described by Shelton et al [16]. 
ULM images were obtained through offline 
post-processing on beamformed IQ data. For in vivo 
studies, frames with breathing induced motion 
artifacts were excluded by calculating the 
frame-to-frame cross-correlation of a chosen region of 
tissue signals. A high-pass spatiotemporal singular 
value decomposition (SVD) filter was applied. The 
decorrelation of bubbles was detected, yielding 
individual sources on the filtered images. This 
spatiotemporal filter can discriminate bubble signals 
whose spatial coherence is low from tissue signals 
whose spatial coherence is high because their 
temporal variations affect many neighboring pixels 
the same way [28]. Hysteresis thresholding was used 
to localize the bubbles on the filtered images. Bubble 
centers were detected and center positions from all 
the frames were accumulated to get a ULM image, 
with a pixel size of 10 µm × 10 µm, for each scan slice. 
An experimental test using the same imaging system 
parameters with a wire target (data not shown) 
indicated that position error of the localization 
process (resolution limit) was about 3.3 µm × 3.3 µm.  
However, a pixel size of 10 µm × 10 µm was chosen 
because the smaller pixel size required a larger 
number of separable events to be detected to 
reconstruct the vasculature map, therefore longer 
acquisition time would be needed. Regardless, 10 µm 
is more than a tenfold resolution increase of 
traditional ultrasound imaging and approaches 
capillary size, we hypothesize it would be more than 
sufficient for resolving tumor microvasculature. The 
ULM process is described in Figure 1, with in vitro 
data from microtubes. 
To verify the ability of ULM technique to 
differentiate healthy tissue and tumors, vascular 
tortuosity was measured from 3D ULM images 
acquired from three controls and three tumor-bearing 
rats. Individual vessels were firstly segmented using 
the Aylward/Bullitt centerline extraction algorithm 
with manually defined seed points [29]. This 
algorithm uses dynamic-scale ridge traversal method 





to segment and extract the centerline of tubular 
objects. Vascular tortuosity was then calculated for 
each vessel, using the distance metric (DM) [30], 
which is defined as the total path length of a vessel, 
divided by the Euclidean distance between vessel 
endpoints. The DM has a minimum value of 1 for a 
straight vessel and increases as the vessel deviates 
from straight. The statistical significance was 
measured by unpaired student t-test with three rats in 
each group. 
Results 
Figure 1 illustrates the bubble detection process. 
In vitro results from microtubes, with inner diameters 
of 150 µm, 75 µm and 50 µm, are shown in Figure 2 
and Table 1. All the three microtubes were measured 
as 171 µm in B mode imaging, because the transmitted 
frequency of 4.5 MHz yields an axial resolution limit 
of 171 µm and all three microtubes were below this 
resolution limit. However, they were resolved with 
ULM, with measured diameter of 140 µm, 65 µm and 
40 µm, respectively. Figure 2 also shows the 
super-harmonic images of the three microtubes for 
visual comparison. The in vitro experimental results 
demonstrate the ability of the ULM technique to 
resolve objects below the resolution limit of 
traditional ultrasound imaging. 
 
Figure 1. Bubble detection process. (A) Acquired beamformed B mode image. (B) Image after using a spatiotemporal filter to remove static and slow-moving signals. (C) 
Localized microbubbles using hysteresis thresholding. (D) Detected bubble center position superposed on a filtered image. 
 
Figure 2. In vitro: ULM images (A-C) and super harmonic images (D-F) of microtubes with inner diameter of 150 µm (A, D), 75 µm (B, E) and 50 µm (C, F). Bar = 200 µm. 






Figure 3. In vivo: ULM images of a 2D slice of a rat FSA tumor and cross-section profiles of three vessels with different size. Bar = 5 mm. 
 
Table 1. Comparison of measured tube size with B mode imaging 
and ULM technique. 
Actual (µm) B mode Imaging ULM 
Measured Size 
(µm) 
Error (%) Measured Size 
(µm) 
Error (%) 
150 171 14 140 6.7 
75 171 128 65 14 
50 171 242 40 20 
 
 
In vivo results from a 2D slice of a rat FSA tumor 
are shown in Figure 3, illustrating detection of vessels 
with diameters between 25 µm and 175 µm. 
Cross-sections of several vessel profiles, indicated by 
lines 1 to 3, are also shown in Figure 3. The full-width 
at half-maximum was measured as the vessel 
diameter size. A branching vessel profile (profile 1) 
shows two vessels at a distance of 27 µm can be 
separated. However, some artifacts are present in 
Figure 3. These artifacts come from the low signal to 
noise ratio (SNR) of our imaging system and transmit 
settings. Therefore, some noise signals are included 
during the bubble identification process. Although 
transmitting pulses of higher pressure and more 
cycles can increase the image SNR, these conditions 
also lead to microbubble deterioration. A complete 3D 
ULM image (maximum intensity projection from all 
the ULM image slices) is displayed in Figure 4C and 
compared with traditional acoustic angiography 
images acquired from the same rat tumor. The 
number of detected events per tumor plane ranges 
from tens of thousands to hundreds of thousands. It is 
difficult to compare the two types of images in exactly 
the same orientation, because they come from 
different imaging system and different probes. 
Therefore, the traditional acoustic angiography 
images are oriented in sagittal anatomic plane and 
coronal anatomic plane for easier comparison. The 
arrows with the same numbers indicate the same 
vessels detected by both techniques. The minimum 
detected vessel size inside the tumor was 
approximately 25 µm, while the resolution limit of 
traditional acoustic angiography with a 25 MHz 
receiver at approximately 1.5 cm is on the order of 150 
µm. Hence, ULM readily resolves more small vessels 
inside the tumor, compared with traditional acoustic 
angiography imaging. Figure 5 presents 3D ULM 
images of the subcutaneous region of the right flank 
from two healthy (control) rats and two rats with 
subcutaneous tumors. Vessel density and 
morphological differences are readily apparent 
between healthy and control tissue. 
To quantitatively analyze the difference of vessel 
tortuosity between control rats and tumor-bearing 
rats, three control rats and three tumor-bearing rats 
were imaged at the same anatomic location 
(subcutaneous region of the right flank) and 
microvessel morphology was compared. The total 
number of vessels analyzed were 379, with 113 vessels 
extracted from control rats and 266 vessels extracted 
from tumor-bearing rats. The distance metric was 
calculated for each segmented vessel. To intuitively 





show how the microvessel morphology yields the 
tortuosity metric, six extracted vessels with different 
morphology and their corresponding DM values were 
presented in Figure 6. Box plots of distance metric for 
the two animal types are shown in Figure 7 and a 
summary of the tortuosity values are shown in Table 
2. An unpaired student t-test shows the tortuosity was 
significantly higher for the tumor rat population than 
for the control rat population, with p < 0.01 (Figure 7). 
The mean and standard deviation of the DM values of 
all the control vessels was 1.106 ± 0.115, whereas the 
tumor vessels had higher DM values of 1.279 ± 0.529, 
representing an increase of 15.64%. The mean 
intra-animal variability is the average intra-animal 
variability across all animals within the population. 
The relative intra-animal variability was calculated by 
normalizing intra-animal variability with the mean 
tortuosity value and is expressed as a percentage. The 
intra-animal variation was 0.110 and 0.580 for control 
and tumor rats, which corresponds to a relative 
deviation of 9.79% and 44.01%, respectively, 
indicating the tumor vascular network is more 
heterogeneous than the normal vascular network. 
Table 2. Summary of tortuosity for control and tumor-bearing 
rats. 
 Control Tumor 
Maximum 1.505 6.655 
Minimum 1.002 1.001 
Mean 1.106 1.279 
Median 1.059 1.136 
Intra-population variability 0.115 0.529 
Mean intra-animal variability 0.110 0.580 





Figure 4. In vivo: Maximum intensity projection through three-dimensional acoustic angiography image data (A, B) and three-dimensional ULM image (C) of a same rat FSA 
tumor. The resulting two-dimensional images are orientated in the sagittal anatomic plane (A) and coronal anatomic plane (B) for acoustic angiography and in the sagittal anatomic 
plane (C) for the ULM image. Bar = 4 mm. 
 
Figure 5. In vivo: Maximum intensity projection through three-dimensional ULM image data for four rats. The resulting two-dimensional images are orientated in the sagittal 
anatomic plane. Vessel density and morphological differences are obvious between the control rats (A, B) and tumor rats (C, D). Bar = 4 mm. 






Figure 6. Six extracted vessels and their corresponding tortuosity metric values. 
 
 
Figure 7. Box plots of the vessel tortuosity (Distance metric) of images from the 
control rat population and tumor-bearing rat population. 
 
Discussion and Summary 
In this study, we presented in vivo images of 
tumor angiogenesis using 3-D ultrasound localization 
microscopy for the first time. Quantitative analysis of 
vascular networks extracted from 3D ULM images 
indicates the potential ability of this technique to 
distinguish healthy from diseased tissue, therefore 
examining tumor associated microvascular 
angiogenesis.  Ultrasound localization microscopy 
can resolve very small vessels inside the tumor, and 
all tumor-bearing rats had significant increase of the 
vessel tortuosity and a higher degree of vascular 
heterogeneity, compared with vessels in the control 
rats. These vascular changes presented in tumors 
agree with the observations by super-harmonic based 
acoustic angiography [13,16] and other imaging 
modalities such magnetic resonance angiography [3].  
Such ultra-high resolution imaging of microvascular 
morphology is a paradigm shift in the capabilities of 
an ultrasound system, largely enabled by advances in 
processing hardware. Although the ultrasound 
system utilized here was a programmable research 
system, it is quite reasonable that commercial systems 
would be able to perform this kind of imaging in the 
clinic in the near future. 
However, there are several significant 
limitations of this study. First, the imaging time 
required to acquire ULM images is long, compared 
with acoustic angiography or traditional ultrasound 
imaging. To reconstruct a super-resolved vasculature 
map, a large number of frames is necessary to capture 
more bubbles flowing in the vessels. Our study used a 
frame rate of 500 Hz and acquired 8,000 images for 
each slice, therefore, imaging one slice needs 26s (16s 
for data acquisition and 10s for data save). A complete 
3D scan of typical sized rat tumors (0.5 cm to 1.5 cm) 
requires imaging time from 11 minutes to 33 minutes, 
when a step size of 200 µm is used. It is beneficial to 
acquire more images for each slice because the 
resolution of ULM depends on the number of bubbles 
detected. Errico et al. 2015 used 78,000 images (150s) 
for a brain cortex single slice with 3.5mm depth, and 
10 minutes of acquisition for a whole brain coronal 
slice with 11.6 mm depth [26]. Their impressive image 
data suggests they detect many more events than us, 
leading to more resolved microvessels.  However, 
note that they imaged in a physiologic location where 
the entire vessels could be visualized in a single plane.  
This single plane approach would not enable 
volumetric analysis of cancer-associated malignancy, 
which is highly spatially heterogeneous. Second, a 
compromise exists between the scan step size and 
imaging time. Imaging with smaller scan step can 
capture more elevational spatial information, 
however, in order to limit the anesthesia time and 
contrast infusion volume with the in-vivo study, we 
kept the imaging time less than 35 minutes. However, 
the frame rate could be increased substantially with 
appropriate hardware, further speeding the 
acquisition time. 
Another drawback lies in the post-processing 
stage. First, frames with breathing induced motion 
artifacts were excluded in our study. Although this 
did effectively avoid interference of bubble positions 
from moving frames, 20%-30% frames were lost 
during this process. Second, the hysteresis 
thresholding method was used to localize bubbles. 
The thresholding values need to be appropriate 
because a too high threshold value can exclude some 





low intensity bubbles while a too low threshold value 
may include some unwanted noise signal. Improved 
motion correction and detection algorithms will 
ameliorate these limitations. 
Finally, our capability to measure tortuosity 
metrics was limited by the fact that the imaging 
technique is challenged to detect vessels in the 
elevational plane and our step size in this plane is 
larger than with traditional acoustic angiography. 
This fact likely limited our sensitivity to microvessel 
morphology. Indeed, differences between microvessel 
tortuosity between healthy and tumor-bearing tissue 
appeared more substantial in previously published 
works using traditional acoustic angiography [13,16]. 
This is a more significant challenge for 3D ULM, 
which may be resolved by 2D matrix transducers or 
other methods to image in the elevational plane. We 
were also not able to effectively calculate the sum of 
angles metric due to challenges in the data format. 
The sum of angles metric is more sensitive to high 
frequency tortuosity differences in malignant 
angiogenesis than distance metric, and has previously 
shown to be a stronger differentiator than the distance 
metric in characterizing malignant angiogenesis [13]. 
Further studies will incorporate this analysis as well. 
Considering the long imaging time, detecting as 
many vessels as possible in each slice within limited 
imaging time becomes crucial. The relationship 
between imaging parameters like bubble size, bubble 
concentration, transmitted wave energy, transmitted 
frequency and the final tumor ULM image quality 
needs to be studied. 
Nevertheless, the performance of ULM for super 
resolution imaging of angiogenesis as a biomarker is 
encouraging, and the utility of this diagnostic tool will 
no doubt play more of a role in theranostics over the 
next decade. 
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